Remedy Plan Therapeutics
PrivateLast Round
Early Funding
May 13, 2025
Total Funding Raised
$19.61M
Company Overview
Remedy Plan Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel, hyperbolic NAMPT inhibitors to treat a range of diseases including solid tumors, hematologic malignancies, obesity, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedy Plan Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Remedy Plan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 13, 2025 | ||||
| Early Funding | Nov 9, 2018 | ||||
| Grant | Sep 20, 2018 | ||||
| Crowdfunding | Nov 6, 2015 |
Remedy Plan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Early Funding |
| Schooner Capital | Early Funding |
| Maryland Tech Council | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Jotin Marango appointed as Chief Financial and Business Officer.
- Jan 1, 2026
Presented multiple times at the AACR Annual Meeting 2026.
Remedy Plan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedy Plan Therapeutics's valuation, stock price, and market status.
